Idiopathic Interstitial Pneumonia Clinical Trial
Official title:
Japanese Idiopathic Interstitial Pneumonias Registry
An objective of JIPS Registry is to examine disease behavior of idiopathic interstitial pneumonias (IIPs), considering classification, background, and diagnostic methods based on American Thoracic Society (ATS)/ European Respiratory Society(ERS) /Japanese Respiratory Society (JRS)/ Latin American Thoracic Association (ALAT) guidelines for diagnosis and the ATS/ERS classification of 2002 and 2013.
JIPS Registry is a multi-site, non-interventional, prospective observation study of patients with newly diagnosed IIPs in Japan. At least 600 patients will be registered for 16 months at approximately 80 sites in Japan. Primary research question is to determine the natural history of each category of IIPs at registration, patient background and diagnosis methods will be considered. Furthermore, the present treatment patterns and disease behavior (CT and forced vital capacity (FVC) changes, as well as changes in interstitial pneumonia markers, etc.) will also be investigated. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02951416 -
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
|
||
Completed |
NCT02036970 -
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
|
Phase 2 | |
Not yet recruiting |
NCT04179058 -
Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up
|
||
Recruiting |
NCT03836417 -
Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
|
||
Recruiting |
NCT01088217 -
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
|
||
Completed |
NCT02594839 -
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
|
Phase 1/Phase 2 | |
Completed |
NCT05146934 -
The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence
|